The latest trading disclosures reveal that Space Exploration Technologies Corp. now claims the firm’s largest allocation by value across multiple exchange-traded funds, including ARKK, ARKQ, ARKW, and ARKX. This purchase cycle builds on earlier efforts to accumulate SpaceX stock following its post-IPO price decline. Wood recently asserted that the company maintains a decade-long lead over industry competitors, with internal models projecting an enterprise value between $2.5 trillion and $3.1 trillion by 2030.
In section Cryptocurrency
Ark Invest pours $52 million into SpaceX as portfolio rebalancing continues
Cathie Wood’s Ark Invest funneled $52.1 million into SpaceX shares during the week ending July 10, marking a aggressive expansion of its aerospace holdings. The move underscores a strategic pivot toward space and AI infrastructure, even as the firm aggressively trimmed its exposure to semiconductor, streaming, and genomics equities.
Beyond aerospace, the firm expanded its footprint in AI and digital finance, picking up shares of Meta Platforms, Coinbase Global, Circle Internet Group, and X-Energy. A diverse array of healthcare and defense-related firms, such as Kratos Defense & Security Solutions and Ionis Pharmaceuticals, also saw increased investment. Conversely, the rebalancing act forced exits or reductions in Advanced Micro Devices, Roku, and Deere. A broad retreat from the genomics sector was also evident, with sell-offs hitting Natera, Illumina, and BioNTech. These adjustments arrive as Ark manages its internal weightings, ensuring no single holding exceeds its 10% portfolio threshold ahead of the second-quarter earnings season.
Comments (0)
No comments yet. Be the first!